Category
Cancer
Sub Category
Myeloma
Study Name
Millennium C16014: A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Must be newly diagnosed
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance